Shenzhen Kangtai Biological Products Co Ltd Class A 300601
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 17.82
- Day Range
- CNY 17.71–18.06
- 52-Week Range
- CNY 17.18–34.18
- Bid/Ask
- CNY 17.78 / CNY 17.79
- Market Cap
- CNY 19.86 Bil
- Volume/Avg
- 8.5 Mil / 9.7 Mil
Key Statistics
- Price/Earnings (Normalized)
- 36.09
- Price/Sales
- 6.18
- Dividend Yield (Trailing)
- 1.01%
- Dividend Yield (Forward)
- 1.01%
- Total Yield
- 1.01%
Company Profile
Shenzhen Kangtai Biological Products Co Ltd is a human vaccine research and development company. The company is engaged in the research and development, production and sales of recombinant hepatitis B vaccine, b -type influenza Haemophilus conjugate vaccine, measles-rubella combined live attenuated vaccine, cell-free baibai broke b Haemophilus influenzae vaccine and other products.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 1,902
- Website
- http://www.biokangtai.com
Comparables
Valuation
|
Metric
|
300601
|
300841
|
300142
|
|---|---|---|---|
Price/Earnings (Normalized) | 36.09 | 12.57 | 39.16 |
Price/Book Value | 2.07 | 2.09 | 2.20 |
Price/Sales | 6.18 | 4.64 | 5.29 |
Price/Cash Flow | 23.74 | 11.40 | 23.99 |
Price/Earnings
300601
300841
300142
Financial Strength
|
Metric
|
300601
|
300841
|
300142
|
|---|---|---|---|
Quick Ratio | 1.47 | 4.14 | 2.46 |
Current Ratio | 2.15 | 4.49 | 2.85 |
Interest Coverage | 2.18 | 119.95 | 47.19 |
Quick Ratio
300601
300841
300142
Profitability
|
Metric
|
300601
|
300841
|
300142
|
|---|---|---|---|
Return on Assets (Normalized) | 3.75% | — | 3.37% |
Return on Equity (Normalized) | 5.79% | — | 5.57% |
Return on Invested Capital (Normalized) | 4.61% | — | 3.91% |
Return on Assets
300601
300841
300142
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Hbnshcmcpn | Btlk | $81.5 Bil | |||
| Merck KGaA ADR
MKKGY
| Vpdqxnfc | Mfxylg | $80.4 Bil | |||
| Haleon PLC ADR
HLN
| Gwylnxll | Nnbpk | $38.6 Bil | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| Fgywjqff | Ggkc | $19.1 Bil | |||
| Viatris Inc
VTRS
| Wblfjrl | Qdfb | $12.7 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Mzvxglkpp | Gyds | $12.0 Bil | |||
| Catalent Inc
CTLT
| Fcgwqjkb | Kkpmgyh | $10.1 Bil | |||
| Perrigo Co PLC
PRGO
| Tftqzdxpx | Vzyl | $3.7 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Lvmrpvt | Lyncc | $3.3 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Hzlkrssb | Ttsvn | $3.2 Bil |